These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8241641)

  • 1. Protection against Campylobacter diarrhea: role of milk IgA antibodies against bacterial surface antigens.
    Torres O; Cruz JR
    Acta Paediatr; 1993 Oct; 82(10):835-8. PubMed ID: 8241641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk.
    Ruiz-Palacios GM; Calva JJ; Pickering LK; Lopez-Vidal Y; Volkow P; Pezzarossi H; West MS
    J Pediatr; 1990 May; 116(5):707-13. PubMed ID: 2329419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk.
    Nachamkin I; Fischer SH; Yang XH; Benitez O; Cravioto A
    Epidemiol Infect; 1994 Apr; 112(2):359-65. PubMed ID: 8150009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants.
    Morrow AL; Ruiz-Palacios GM; Altaye M; Jiang X; Guerrero ML; Meinzen-Derr JK; Farkas T; Chaturvedi P; Pickering LK; Newburg DS
    Adv Exp Med Biol; 2004; 554():443-6. PubMed ID: 15384621
    [No Abstract]   [Full Text] [Related]  

  • 5. The protective effect of human milk against diarrhea. A review of studies from Bangladesh.
    Glass RI; Stoll BJ
    Acta Paediatr Scand Suppl; 1989; 351():131-6. PubMed ID: 2692384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast milk anti-Escherichia coli heat-labile toxin IgA antibodies protect against toxin-induced infantile diarrhea.
    Cruz JR; Gil L; Cano F; Caceres P; Pareja G
    Acta Paediatr Scand; 1988 Sep; 77(5):658-62. PubMed ID: 3059753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.
    Kirkpatrick BD; Lyon CE; Porter CK; Maue AC; Guerry P; Pierce KK; Carmolli MP; Riddle MS; Larsson CJ; Hawk D; Dill EA; Fingar A; Poly F; Fimlaid KA; Hoq F; Tribble DR
    Clin Infect Dis; 2013 Oct; 57(8):1106-13. PubMed ID: 23840001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of anti-Campylobacter-flagellin IgA antibodies in breast milk.
    Renom G; Kirimat M; Georges AJ; Philippe JC; Martin PM
    Res Microbiol; 1992 Jan; 143(1):93-8. PubMed ID: 1641516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation of chickens to reduce intestinal colonisation with Campylobacter jejuni.
    Widders PR; Perry R; Muir WI; Husband AJ; Long KA
    Br Poult Sci; 1996 Sep; 37(4):765-78. PubMed ID: 8894221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana.
    Shapiro RL; Lockman S; Kim S; Smeaton L; Rahkola JT; Thior I; Wester C; Moffat C; Arimi P; Ndase P; Asmelash A; Stevens L; Montano M; Makhema J; Essex M; Janoff EN
    J Infect Dis; 2007 Aug; 196(4):562-9. PubMed ID: 17624842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants.
    Morrow AL; Ruiz-Palacios GM; Altaye M; Jiang X; Guerrero ML; Meinzen-Derr JK; Farkas T; Chaturvedi P; Pickering LK; Newburg DS
    J Pediatr; 2004 Sep; 145(3):297-303. PubMed ID: 15343178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients.
    Ismail TF; Wasfy MO; Oyofo BA; Mansour MM; El-Berry HM; Churilla AM; Eldin SS; Peruski LF
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):536-9. PubMed ID: 9302201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Campylobacter jejuni and Campylobacter coli antigens with mucosal and systemic antibodies.
    Wu SJ; Pacheco ND; Oprandy JJ; Rollwagen FM
    Infect Immun; 1991 Aug; 59(8):2555-9. PubMed ID: 1855976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against Campylobacter jejuni.
    Scott DA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S183-8. PubMed ID: 9396708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and breast milk antibodies to food antigens in African mothers and relation to their diet.
    Mascart-Lemone F; Donnen P; Paluku B; Brasseur D; Van den Broeck J; Vaerman JP; Hennart P; Duchateau J
    Adv Exp Med Biol; 1991; 310():201-6. PubMed ID: 1808999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.
    Tribble DR; Baqar S; Scott DA; Oplinger ML; Trespalacios F; Rollins D; Walker RI; Clements JD; Walz S; Gibbs P; Burg EF; Moran AP; Applebee L; Bourgeois AL
    Infect Immun; 2010 Apr; 78(4):1750-9. PubMed ID: 20086085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of immunological efficiency induced by Campylobacter jejuni PEB1 DNA combined with PEB1 protein in mice].
    Liu L; Lai W; Hu N; Zhang W; Chen T; Wang F; Gu R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):576-80. PubMed ID: 24909276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term antibody responses following human infection with Campylobacter jejuni.
    Cawthraw SA; Feldman RA; Sayers AR; Newell DG
    Clin Exp Immunol; 2002 Oct; 130(1):101-6. PubMed ID: 12296859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
    Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
    Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.